Article info

Download PDFPDF

Letter
Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis
Free

Authors

  1. Correspondence to J M Ramos, Department of Internal Medicine, Hospital General Universitario, Alicante, Pintor Alonso, 12, Alicante 03010, Spain; jramosrincon{at}yahoo.es
View Full Text

Citation

Ramos JM, Vidal I, Bellot P, et al
Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis

Publication history

  • Received February 18, 2015
  • Accepted March 7, 2015
  • First published April 1, 2015.
Online issue publication 
December 08, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.